1 Separating Myth from Fact Myth : Anyone can take GLP-1 weight-loss drugs
Stackhaus Research reserves the right to refuse sales to any individual or entity suspected of misuse
1) has led to the development of the glucagon-like peptide-1 (GLP-1) receptor agonists (RA) as safe and effective treatments for T2D and obesity
If the primary goal is weight loss without underlying metabolic conditions, lifestyle changes like diet and exercise may be more effective in the long run
Women researchers typically use far lower doses, usually 5mg to 10mg weekly, focusing on the metabolic and body composition benefits while minimizing androgenic effects
Bliddal H, Bays H, Czernichow S, Uddn Hemmingsson J, Hjelmesth J, Hoffmann Morville T, et al